The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
Presented by The Webinar Vet and Vet Dynamics, the Vet Trust Awards celebrate notable contributions to veterinary advancement.
Claire Towers, General Manager of Hill’s Pet Nutrition UK and Ireland said: “Our recognition as the most trusted pet food brand is a testament to the unwavering dedication of the Hill’s team, ensuring vets remain integral to our mission.”
The six-floor building, which the College bought for £22.3m in 2022, was originally a warehouse.
Over the years it has been home to a range of businesses from leather manufacturers and papers makers to lithographic plate makers and shoe upping manufacturers, before becoming an office space.
The building remained tenanted until 2024, when £5.8m worth of renovation work to convert the building into a space suitable for a royal college began.
In addition to the working areas for RCVS and RCVS Knowledge staff, the building also has:
RCVS CEO, Lizzie Lockett, said: “After a few years in a rented co-working office space, we’re delighted to have moved into our new home, designed not only to meet the needs of College staff, but to support the broader ambitions of the RCVS as a whole.
“Our new strategic plan has collaboration at its heart – the idea of being stronger through working together – and our new building will help us to achieve that.
“Whether attending events, exploring RCVS Knowledge’s archives, using the members' area and meeting rooms, or benefitting from the outputs that the new space enables, the building has been developed with members and associates as a central focus.”
RCVS President, Linda Belton, added: "It’s great to see what’s been achieved through this project and my thanks go to the team who have managed the refurbishment and move.
“The new premises are equipped to ensure that the voice of the veterinary professions remains integral in assuring animal health, welfare, and public health in the UK, allowing for those all-important stakeholder conversations essential to setting, upholding and advancing veterinary standards.
“We look forward to welcoming members, associates, students and stakeholders alike in the coming months and years.”
The theme for the symposium this year is ‘Advancing veterinary mental health research: learning from the past, considering the present, and looking to the future’.
The day will consist of a variety of oral presentations and poster presentations, and there will be a number of exhibitors, including charitable organisations and wider animal health and welfare organisations.
The College is inviting all those interested in the field of veterinary mental health to attend the day.
RCVS Council member and Chair of the Mind Matters Initiative, Dr Louise Allum, said: “Our symposium presents a fantastic opportunity for knowledge exchange in the veterinary mental health sphere so that, together, we can continue to foster a compassionate environment and build a solid evidence-base for veterinary mental health research to grow and evolve.
“This is an inclusive event open to all with an interest in veterinary mental health including vets, nurses, students, practice managers, academics, healthcare professionals, policy makers, mental health advocates and everyone in between.”
MMI Lead Rapinder Newton added: “We have come a long way in developing our understanding of mental health in veterinary professionals over the past ten years but still have a way to go.
“Only through continued collaboration with mental health researchers, and learning from other allied professions, can we efficiently work towards our shared goal of enhancing mental health and support within the veterinary professions.
“This is why events such as our symposium are so important.
"Veterinary mental health is a small but growing field. Creating environments for open discussion and networking are key to advancing our understanding of where the challenges lie.
"By extension, this also plays an invaluable role in learning how research can be applied in a practical manner to help improve the lives of veterinary professionals which, ultimately, aids in upholding animal health and welfare too.”
https://www.eventbrite.co.uk/e/mind-matters-initiative-research-symposium-2025-tickets-1247144485729
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
BSAVA Congress was first held in London in 1958, when 245 vets attended.
In 1991, it became the first organisation to host its annual congress at the newly-built ICC Birmingham, where it remained for nearly three decades, growing from an initial 1,800 delegates to welcoming 10,000 delegates and exhibitors in 2012.
Somehow, though, it never lost that sense of community that came with it being the annual event of a membership association.
The editor of this website has many fond memories, including delivering bottles of 'Bugwiser', 'Kronenbug', 'Carlsbug', 'Catfleas' (Caffreys) and 'Bug Iced' to delegates' hotel bedrooms to promote Program flea treatment and organising a spoof protest march against fleas with the charity Dogs for the Disabled, which proved immune to the ICC security team (one of whom was heard radioing: "But we can't move them on, they're in wheelchairs".
However, in 2009, competition arrived in the form of the London Vet Show.
In 2018, the decision was made to move Congress North to Manchester, but then of course COVID hit, forcing the cancellation of the last Birmingham Congress and the first Manchester one in 2021.
Sadly, there was probably never going to be room for two major congresses for the veterinary profession - especially with the rise of online learning - and the one in the capital city was always likely to win that particular battle.
BSAVA says it is now focussing its resources on new initiatives that it believes will better serve its members.
President Julian Hoad said: “The BSAVA needs to adapt as the landscape changes and as the profession continues to innovate and grow.
"We’ve conducted extensive research with our members on their education and development needs and the future requirements of the wider profession.
"It’s clear that we need to adapt to offer more agile solutions which will bring huge benefits to vets and veterinary nurses.
"With that in mind, the BSAVA has decided that it’s time to retire Congress.
"We believe we will deliver better value to our members by pursuing new opportunities and developing more versatile product innovations.
"As an organisation we’re extremely proud of the legacy Congress leaves behind.
"It's been a cherished and valuable event for the profession over the last 68 years, and we want to thank all who’ve been part of that legacy.”
Apparently the commonly reported use of AI technology was for radiography diagnostics and reporting (44%), followed by laboratory diagnostics and reporting (27%), communications with clients (11%) or to assist with administrative work (7%).
Vets were asked about the benefits and risks of using AI technology in their work.
The most common reported benefit was data interpretation (55%), followed by diagnostic testing (49%), saving time more generally (40%) and for routine admin tasks or note taking (38%).
The most commonly reported risks of AI were the possibility that results are interpreted without context (83%) or that AI is used incorrectly, without follow up checks (82%).
The other reported risks were an overreliance on AI undermining human skills (68%) and a lack of data protection (25%).
BVA Junior Vice President Rob Williams said: “It’s fascinating to see how many vet teams are already using AI technology in their daily work.
"The massive boom in the use of these tools represents an exciting opportunity for the profession, particularly around diagnostics and interpreting large data sets.
"But as well as benefits there are clear challenges and risks, so this timely session is a great opportunity to address some of the ethical questions around the use of technology when it comes to treating animals and ensuring their welfare.
"It’s set to be an interesting debate, with the chance for delegates to pose questions to our incredibly knowledgeable panel, and I hope many of you will join us to add your voice to the discussion.”
On the AI discussion panel at BVA Live will be: Nick Jackson, Director, Veterinary Surgeon, Council Member - NGJ Locum Ltd, Ben O'Halloran, Policy Officer - BVA and Nicolò Frisiani, Co-founder and CEO - Lupa Pets.
https://bvalive.vetshow.com/conference-programme
Photo: www.depositphotos.com
Biomérieux says the new test, which is used on the Biofire Spotfire System, detects seven infectious respiratory pathogens (six viruses and/or a strain of bacteria*), from a nasopharyngeal swab, in under 20 minutes.
The company says the new test’s ability to distinguish between viral and bacterial infections is important for ensuring antibiotics are used appropriately to reduce the risk of resistance.
Biomérieux says VetFire can be used to make informed decisions about when to isolate and treat animals when respiratory infections are suspected, to mitigate the impact of an outbreak in a contained area, such as a yard, by allowing rapid quarantine measures, and perhaps in time as a standard test ahead of animals travelling for competition, to ensure they are fit and healthy.
VetFire is commercially available in United Kingdom, Ireland and France, with possible expansion plans to other countries in the near future.
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vetfire.html
*Equine Herpesvirus type 1, Equine Herpesvirus type 4, Influenza A, Equine Rhinovirus A, Equine Rhinovirus B, Equine Adenovirus 1, Streptococcus equi equi
The maps provide vets with a visual representation of targeted diagnostic tests conducted in France, Germany, Ireland, Italy, Spain, and the UK, using data sourced from Idexx.
They show the percentage of positive test results for a range of parasites and parasite-associated infections in dogs and cats, including Giardia, roundworm, and whipworm, and Lyme (Borrelia burgdorferi), Ehrlichia spp., Anaplasma spp., Babesia spp., and Leishmania in dogs.
Data can be filtered by country, region, animal species, parasite type, and time period.
ESCCAP highlights that the data reflects the percentage of positive tests in screened animals, not the overall prevalence of infection.
https://www.esccap.org/parasite-infection-map/